Skip to main content

Gabriela Guillén Burrieza

I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncological Surgery
Children's Hospital and Woman's Hospital

Gabriela Guillén Burrieza

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncological Surgery
Children's Hospital and Woman's Hospital

I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care.

Graduated in Medicine from the University of Salamanca, I did my specialty training in Pediatric Surgery at Vall d'Hebron Hospital. Since 2008 I have been part of the Pediatric Surgery department, first as an staff member and currently as head of section.
Between 2008 and 2017 I was also tutor for doctors in training.

My main area of ​​specialization is pediatric surgical oncology, where I have focused most of my clinical practice and research projects, although other areas of my interest are neonatal, hepatobiliary and thoracic surgery.

I have been a member of the European Pediatric Soft Tissue Sarcoma Study Group since 2012, first as part of the surgical subcommittee and since 2020, as part of the Board. In addition, I belong to and collaborate with other European pediatric cancer expert groups (SIOPEN, RTSG, EXPERT, SIOPEL), international (IPSO) and I am consultant for several national groups (SEHOP groups in soft tissue sarcomas, rare tumors and renal tumors ). Since 2024, I have been president of GRECOP (Spanish Group of Pediatric Surgical Oncology).

In 2023, I presented my PhD at the Universitat Autònoma de Barcelona, ​​titled "Development of Orthotopic PDX (Patient-Derived Xenografts) for Pediatric Extracranial Solid Tumors", focused on the generation of preclinical models in childhood cancer, achieving an excellent Cum Laude qualification.

To date, I have published more than 70 scientific papers and book chapters, as an author or co-author, and I participate in several research projects both in pediatric cancer and in other areas of my specialty. I currently combine several research projects in pediatric cancer, as a member of the research group in Cancer and Children's Hematological Diseases of the VHIR, with more purely surgical projects (applications of intraoperative fluorescence, 3D reconstructions, development of minimally invasive techniques, projects of humanization in surgery, among others).

Projects

Bioenginyeria, ortopèdia i cirurgia pediàtriques

IP: César Galo García Fontecha
Collaborators: Roberto Vélez Villa, Margarita Codinach Creus, Vicenç Martínez Ibáñez, José Luis Peiró Ibáñez, Carlos Giné Prades, Francisco Soldado Carrera, Màrius Aguirre Canyadell, Luciano Rodríguez Gómez, Carles Amat Mateu, Mario Marotta Baleriola, Gabriela Guillén Burrieza
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 130
Duration: 01/01/2010 - 30/04/2014

Related news

The study, led by Dr. Lucas Moreno and University of Birmingham shows that the combined administration of chemotherapy and immunotherapy with the antibody dinutuximab beta achieves a better treatment response.

The donation will support a project investigating new therapeutic approaches in pediatric brain tumors

The €15,000 donation will boost research into this very rare type of childhood cancer.

Related professionals

Aurora Gil Velazquez

Aurora Gil Velazquez

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Pilar Lusilla Palacios

Pilar Lusilla Palacios

Psychiatry, Mental Health and Addictions
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Fiorella Dellepiane Clarke

Fiorella Dellepiane Clarke

Postdoctoral researcher
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.